While standard models suffer from context rot as data grows, MIT’s new Recursive Language Model (RLM) framework treats ...

Researchers at MIT's CSAIL published a design for Recursive Language Models (RLM), a technique for improving LLM performance on long-context tasks. RLMs use a programming environment to recursively ...

For decades, artificial intelligence advanced in careful, mostly linear steps. Researchers built models. Engineers improved performance. Organizations deployed systems to automate specific tasks. Each ...

Blockchain networks face a quiet but serious problem that grows over time. As transactions pile up, nodes must store more ...

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...

Cloudflare experienced a "spike in unusual traffic” shortly before errors broke out across many major websites it serves, the internet infrastructure company told Newsweek. Read the full story here.

In “Straight Talk with Rick and Jal,” Harvard University’s Jal Mehta and I examine the reforms and enthusiasms that permeate education. In a field full of buzzwords, our goal is simple: Tell the truth ...

Morgan Wallen is bringing his "Still the Problem" tour to stadiums across the country. Unfortunately for hometown fans, Neyland Stadium did not make the cut. But there's hope. The Knoxville star ...

The tour will include two-night-stands at stadiums in all but one of the 11 cities on the itinerary, for a total 21 shows. Morgan Wallen, riding high off the success of “I’m the Problem,” the ...

Looking at challenges outside of your own company can lead to powerful change. Rosabeth Moss Kanter, professor at Harvard Business School, believes the world demands a new kind of business leader. She ...

That’s how Meta’s chief AI scientist Yann LeCun described the blowback after OpenAI researchers did a victory lap over GPT-5’s supposed math breakthroughs. Google DeepMind CEO Demis Hassabis added, ...

The last time I wrote about Recursion Pharmaceuticals (RXRX), it was with respect to a Seeking Alpha article entitled "Recursion: CDK7 Differentiation Is Initially Paying Off." With respect to this ...